Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -77.39%46.85M | 0.25%112.81M | 5.30%91.94M | 76.70%686.06M | 166.57%279.03M | 39.38%207.18M | 11.26%112.53M | 158.34%87.32M | 3,318.02%388.25M | 1,920.68%104.67M |
| Net profit before non-cash adjustment | 36.14%66.4M | -28.82%61.35M | 8.53%65.33M | 120.27%267.03M | -10.00%71.88M | 1,450.72%48.77M | 279.24%86.19M | 288.55%60.19M | 248.25%121.23M | 840.38%79.87M |
| Total adjustment of non-cash items | -35.12%48.21M | -52.78%32.5M | -31.34%50.63M | 9.17%293.15M | -12.08%76.28M | 6.07%74.31M | 23.11%68.82M | 32.17%73.74M | 24.37%268.52M | 1.26%86.77M |
| -Depreciation and amortization | -23.85%48.38M | -3.11%57.31M | -25.21%49.1M | 21.65%245.67M | 5.66%57.34M | 16.89%63.54M | 28.93%59.15M | 38.38%65.65M | 20.25%201.94M | 1.89%54.27M |
| -Reversal of impairment losses recognized in profit and loss | -96.27%125K | ---- | ---- | 1,050.68%2.52M | -20.14%-847K | 1,467.76%3.36M | 300.00%12K | --0 | -54.28%219K | -413.33%-705K |
| -Assets reserve and write-off | ---- | ---- | ---- | -33.54%17.64M | ---- | ---- | ---- | ---- | -5.75%26.55M | ---- |
| -Share of associates | -87.50%-105K | 14.58%-41K | 83.02%-9K | -127.96%-212K | -12.24%-55K | -343.48%-56K | -11.63%-48K | -120.83%-53K | 40.00%-93K | -16.67%-49K |
| -Disposal profit | 12.76%-1.18M | 20.30%-1.5M | 38.34%-1.66M | -103.43%-8.36M | -87.17%-2.42M | -50.17%-1.36M | -71.23%-1.89M | -232.76%-2.69M | -19.18%-4.11M | -652.33%-1.29M |
| -Net exchange gains and losses | 35.30%-1.98M | 73.62%1.73M | -222.85%-414K | -29.50%-3M | 67.32%-1.28M | -154.85%-3.06M | 458.63%997K | 109.09%337K | 72.77%-2.32M | 44.72%-3.9M |
| -Remuneration paid in stock | -8.78%1.07M | -11.90%1.04M | -7.20%1.11M | 485.86%4.64M | 37.37%1.09M | --1.17M | --1.19M | --1.19M | 189.90%792K | 204.35%792K |
| -Pension and employee benefit expenses | ---- | ---- | ---- | 145.38%226K | 142.48%226K | --0 | --0 | --0 | -204.40%-498K | -215.90%-532K |
| -Other non-cash items | -82.30%1.9M | -377.78%-26.15M | -73.04%2.51M | -26.10%34.03M | -60.60%4.59M | -0.76%10.71M | -17.55%9.41M | -23.57%9.31M | 44.62%46.04M | 0.30%11.65M |
| Changes in working capital | -180.56%-67.76M | 144.64%18.96M | 48.48%-24.02M | 8,508.68%125.88M | 311.19%130.86M | 11.49%84.11M | -288.73%-42.48M | -24.36%-46.61M | 98.78%-1.5M | 11.13%-61.96M |
| -Change in receivables | -164.50%-70.63M | 142.63%36.76M | 128.02%16.63M | 262.29%35.44M | 789.98%71.5M | 237.29%109.51M | -567.16%-86.24M | -20.65%-59.33M | 106.83%9.78M | 111.40%8.03M |
| -Change in inventory | 67.02%5.54M | -75.95%5.33M | -86.59%3.1M | 337.86%30.79M | -217.87%-17.8M | 209.65%3.32M | 305.20%22.14M | 336.45%23.13M | 52.55%-12.95M | 55.84%-5.6M |
| -Change in payables | 90.72%-2.67M | -207.01%-23.13M | -320.08%-43.74M | 3,478.34%59.65M | 219.83%77.17M | -162.43%-28.72M | 1,626.27%21.61M | -148.48%-10.41M | -96.50%1.67M | -579.72%-64.4M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 66.36%-5.57M | -128.95%-20.15M | -196.39%-8.37M | -318.24%-50.47M | -152.57%-22.3M | -214.34%-16.55M | -362.22%-8.8M | -112.26%-2.82M | 17.43%-12.07M | 13.37%-8.83M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -78.35%41.28M | -10.67%92.66M | -1.09%83.58M | 68.96%635.59M | 167.86%256.73M | 32.96%190.64M | -0.73%103.73M | 160.23%84.5M | 11,653.62%376.19M | 2,012.25%95.84M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 52.15%-49.01M | -123.18%-53.07M | -18.34%-38.37M | -147.60%-264.95M | -473.59%-106.32M | -71.92%-102.43M | -25.22%-23.78M | -227.40%-32.42M | 27.40%-107.01M | 49.91%-18.54M |
| Net investment product transactions | --0 | --0 | --0 | 200.00%6.64M | --0 | --0 | 158.99%6.7M | 92.39%-61K | -109.68%-6.64M | 1,475,900.00%14.76M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 2,488.89%233K | ---- |
| Interest received (cash flow from investment activities) | -40.76%1.23M | 5.25%1.38M | 21.50%1.54M | 80.17%7.23M | 81.24%2.57M | 215.13%2.08M | 16.70%1.31M | 56.37%1.27M | 16.75%4.01M | 112.91%1.42M |
| Investing cash flow | 52.39%-47.77M | -227.89%-51.68M | -17.98%-36.83M | -129.50%-251.07M | -4,782.35%-103.75M | -47.23%-100.35M | 46.06%-15.76M | -215.46%-31.22M | -45.23%-109.4M | 94.15%-2.13M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | ---21.99M | -85.85%-35.72M | 24.75%-169.86M | 12.95%-64.74M | -10.46%-85.9M | --0 | -531.81%-19.22M | -342.75%-225.73M | -725.05%-74.36M |
| Net common stock issuance | ---- | ---- | ---- | --9K | ---- | ---- | ---- | ---- | --0 | ---- |
| Increase or decrease of lease financing | ---912K | 150.33%526K | -131.80%-2.33M | -18.57%-5.09M | -20.01%-3.04M | --0 | -45.14%-1.05M | 3.37%-1M | -7.11%-4.29M | 32.34%-2.53M |
| Cash dividends paid | --0 | ---- | ---- | ---41.08M | ---20.54M | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | 76.00%-1.83M | 66.45%-2.26M | 74.43%-2M | 26.82%-34.03M | 18.72%-11.86M | 29.79%-7.61M | 42.80%-6.73M | 15.83%-7.83M | -99.53%-46.5M | -154.82%-14.59M |
| Net other fund-raising expenses | -91.50%147K | ---- | ---- | 514.06%5.77M | 176.35%3.73M | 305.10%1.73M | -1,559.08%-5.39M | 652.11%5.7M | 124.91%939K | 198.04%1.35M |
| Financing cash flow | 97.18%-2.59M | -336.82%-147.25M | -79.18%-40.05M | 11.36%-244.27M | -6.99%-96.43M | -2.61%-91.78M | 62.90%-33.71M | -335.82%-22.35M | -235.82%-275.58M | -353.89%-90.13M |
| Net cash flow | ||||||||||
| Beginning cash position | -33.30%137.83M | 65.62%253.21M | 106.60%247.52M | 5.72%119.81M | 87.01%195.09M | 74.41%206.64M | 16.56%152.89M | 5.72%119.81M | -53.65%113.32M | -38.49%104.32M |
| Current changes in cash | -510.07%-9.08M | -295.86%-106.27M | -78.33%6.7M | 1,694.61%140.25M | 1,477.68%56.54M | 89.53%-1.49M | 447.83%54.26M | 77.30%30.93M | 94.53%-8.8M | 105.86%3.58M |
| Effect of exchange rate changes | 93.07%-697K | -1,692.91%-9.11M | -147.28%-1.02M | -182.02%-12.53M | -134.58%-4.12M | -14,888.24%-10.06M | -117.45%-508K | 436.75%2.15M | -48.15%15.28M | 142.16%11.9M |
| End cash Position | -34.37%128.05M | -33.30%137.83M | 65.62%253.21M | 106.60%247.52M | 106.60%247.52M | 87.01%195.09M | 74.41%206.64M | 16.56%152.89M | 5.72%119.81M | 5.72%119.81M |
| Free cash flow | -108.79%-7.73M | -47.80%39.6M | -9.12%45.21M | 36.82%364.4M | 102.60%150.86M | 4.94%87.94M | -11.29%75.85M | 120.45%49.75M | 276.80%266.34M | 285.11%74.46M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.